EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Clinicopathological Features and Exploratory Outcome Associations of Bone Marrow Fibrosis in Newly Diagnosed Acute Lymphoblastic Leukemia: A Single‐Center Retrospective Cohort Study

Ying Chen, Si-Heng Liu, Cen-Xia Ran, Wu-Chen Yang, Jia Li, Xian-Gui Peng, Lei Gao, Li Gao iD, Yi-Mei Feng, Qin Wen, Jun Rao, Pei-Yan Kong und 2 weitere

Cancer Medicine · 2026

DOI: 10.1002/cam4.72339 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Cancer Medicine, 2026. Verfasst von Ying Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Medical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis, Bone Marrow. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Chongqing Science and Health Collaborative Major Project on Medical Science and Technology Innovation, Key Project of Chongqing Natural Science Foundation Innovation and Development Joint Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone marrow fibrosis (MF) reflects stromal remodeling and has been associated with treatment resistance and adverse outcomes in hematologic malignancies; however, its clinical significance in acute lymphoblastic leukemia (ALL) remains uncertain. We retrospectively analyzed 103 patients with newly diagnosed ALL and documented MF grades between 2018 and 2023, comparing patients with MF grades 0–1 and those with MF grades 2–3. Higher‐grade MF was present in 50 patients (48.5%). B‐ALL accounted for a greater proportion of cases in the MF 2–3 group than in the MF 0–1 group (94.0% vs. 69.8%; nominal p = 0.002), and this difference remained statistically significant after false discovery rate correction. No mutation‐level difference between the MF groups remained significant after correction for multiple comparisons. In Cox regression, MF 2–3 was associated with a lower observed hazard of death compared with MF 0–1 (adjusted HR, 0.26; 95% CI, 0.12–0.55; p < 0.001). A similar association was observed in a sensitivity analysis restricted to patients with B‐ALL (adjusted HR, 0.30; 95% CI, 0.13–0.70; p = 0.005). Given the retrospective design, limited number of deaths, and potential residual confounding, this unexpected inverse association should be considered exploratory and should not be interpreted as evidence of a biologically protective effect of MF. In conclusion, higher‐grade MF was common in newly diagnosed ALL and was associated with B‐lineage disease. An unexpected inverse association between MF grade and observed mortality was identified in this cohort and persisted in the B‐ALL‐restricted sensitivity analysis. External validation is required before MF can be considered for prognostic stratification or treatment decision‐making.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Precursor Cell Lymphoblastic Leukemia-LymphomaPrimary MyelofibrosisBone MarrowHumansRetrospective StudiesFemaleMaleAdolescentPrognosisAdultChildYoung AdultChild, PreschoolMiddle Aged

Stichwörter der Autor:innen

acute lymphocytic leukemiabone marrow fibrosishematopoietic stem cell transplantationprognostication

Autor:innen und Institutionen

  • Medical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, China.
  • Key Laboratory of Hematology and Microenvironment, Chongqing, China.
  • State Key Laboratory of Trauma and Chemical Poisoning, Army Medical University, Chongqing, China.

ORCID-Profile: Li Gao, Cheng Zhang

Förderung

  • National Natural Science Foundation of China
  • Chongqing Science and Health Collaborative Major Project on Medical Science and Technology Innovation
  • Key Project of Chongqing Natural Science Foundation Innovation and Development Joint Fund
  • Clinical Research Special Project of the Second Affiliated Hospital, the Army Medical University

Zitieren

APA

Chen, Y., Liu, S. H., Ran, C. X., Yang, W. C., Li, J., Peng, X. G., Gao, L., Gao, L., Feng, Y. M., Wen, Q., Rao, J., Kong, P. Y., Zhang, X., & Zhang, C. (2026). Clinicopathological Features and Exploratory Outcome Associations of Bone Marrow Fibrosis in Newly Diagnosed Acute Lymphoblastic Leukemia: A Single‐Center Retrospective Cohort Study. Cancer Medicine. https://doi.org/10.1002/cam4.72339

Vancouver

Chen Y, Liu SH, Ran CX, Yang WC, Li J, Peng XG, et al. Clinicopathological Features and Exploratory Outcome Associations of Bone Marrow Fibrosis in Newly Diagnosed Acute Lymphoblastic Leukemia: A Single‐Center Retrospective Cohort Study. Cancer Medicine. 2026. doi:10.1002/cam4.72339

BibTeX
@article{Chen2026,
  author = {Chen, Ying and Liu, Si-Heng and Ran, Cen-Xia and Yang, Wu-Chen and Li, Jia and Peng, Xian-Gui and Gao, Lei and Gao, Li and Feng, Yi-Mei and Wen, Qin and Rao, Jun and Kong, Pei-Yan and Zhang, Xi and Zhang, Cheng},
  title = {Clinicopathological Features and Exploratory Outcome Associations of Bone Marrow Fibrosis in Newly Diagnosed Acute Lymphoblastic Leukemia: A Single‐Center Retrospective Cohort Study},
  journal = {Cancer Medicine},
  year = {2026},
  doi = {10.1002/cam4.72339}
}
Kostenlos starten →